Schroeder, B
Here a double-blinded, randomized (1:1), placebo-controlled trial using semaglutide 2.4 mg weekly (BARI-STEP) recruited adult participants at least 1 year after gastric bypass or sleeve gastrectomy with a suboptimal clinical response, defined as less than 20% weight loss from surgery
The plaintiff, who began taking Wegovy in May 2023, alleges that she developed ileus, a blockage in the small intestine, followed by a diagnosis of gastroparesis, a condition that affects the stomachs ability to empty normally
The Science Behind GLP-1s and PCOS Women with PCOS have been told for decades to "just eat less and exercise more." But when your cells are resistant to insulin, your body fights backstoring fat instead of burning it, no matter how hard you try
Heartburn and gastroesophageal reflux disease (GERD) symptoms have been reported by patients taking semaglutide and other GLP-1 medications for weight loss